Development Level

Tbio 4 | 10,625
Tchem 1 | 1,890

Disease

Obesity 5 | 616
Anorexia nervosa 4 | 59
diabetes mellitus 4 | 1,663
Alzheimer's disease 3 | 644
Asthma 3 | 349
Cancer 3 | 2,346
Hyperglycemia 3 | 120
Hypertension 3 | 287
Metabolic syndrome X 3 | 155
Schizophrenia 3 | 501
Seizures 3 | 95
psoriasis 3 | 6,685
Alcohol dependence 2 | 107
Amenorrhea 2 | 60
Anxiety Disorders 2 | 37
Arthritis 2 | 248
Autistic Disorder 2 | 320
Bulimia nervosa 2 | 15
Cerebrovascular disease 2 | 231
Cocaine-Related Disorders 2 | 88
Epilepsy 2 | 346
Heart disease 2 | 279
Huntington's disease 2 | 72
Hyperactive behavior 2 | 31
Hyperinsulinism 2 | 63
Hypertensive disease 2 | 193
Hyperthyroidism 2 | 50
Hypoglycemia 2 | 81
Hypogonadism 2 | 70
Hypothyroidism 2 | 89
Kidney disease 2 | 396
Klinefelter's syndrome 2 | 59
Major Depressive Disorder 2 | 106
Migraine 2 | 79
Narcolepsy 2 | 58
Osteoporosis 2 | 257
Rhinitis 2 | 46
Tachycardia 2 | 17
pilocytic astrocytoma 2 | 3,086
Acanthosis nigricans 1 | 14
Alcoholic Intoxication, Chronic 1 | 41
Amnesia 1 | 17
Anorexia 1 | 15
Anovulation 1 | 20
Anxiety disorder 1 | 22
Arthritis, Experimental 1 | 39
Bradycardia 1 | 24
Bronchitis, Chronic 1 | 9
Cardiac Arrhythmia 1 | 20
Catalepsy 1 | 15
Complex regional pain syndrome 1 | 12
Depressive disorder 1 | 48
Eating disorder 1 | 24
Epicondylitis 1 | 19
Epilepsy, Temporal Lobe 1 | 23
Fatty Liver 1 | 48
Fatty liver disease 1 | 84
Female infertility 1 | 28
Fibromyalgia 1 | 22
Gastroenteritis 1 | 46
Gastrointestinal system disease 1 | 50
Gestational Diabetes 1 | 17
Goiter 1 | 27
Hepatitis C 1 | 90
Heroin dependence 1 | 30
Hyperprolactinemia 1 | 22
Hypopituitarism 1 | 36
Inflammation 1 | 109
Insulin Resistance 1 | 48
Irritable bowel syndrome 1 | 59
Kidney failure 1 | 39
Leukemia, Myelocytic, Acute 1 | 113
Lipodystrophy 1 | 32
Liver Cirrhosis, Experimental 1 | 108
Liver disease 1 | 219
Mammary Neoplasms 1 | 410
Melancholia 1 | 12
Memory Disorders 1 | 36
Mood disorder 1 | 10
Muscle Rigidity 1 | 5
Nerve Degeneration 1 | 73
Non-alcoholic Fatty Liver Disease 1 | 40
Obesity, Morbid 1 | 6
Obstructive sleep apnea 1 | 28
Pain 1 | 70
Pain agnosia 1 | 99
Periodontal disease 1 | 37
Phaeochromocytoma 1 | 20
Prader-Willi syndrome 1 | 45
Pseudohypoparathyroidism 1 | 17
Respiratory Insufficiency 1 | 11
Stereotypic movement disorder 1 | 6
Substance Withdrawal Syndrome 1 | 52
Thyroiditis 1 | 25
Thyrotoxicosis 1 | 38
Weight Gain 1 | 87
Weight decreased 1 | 18
chronic kidney disease 1 | 90
facioscapulohumeral dystrophy 1 | 286
post-traumatic stress disorder 1 | 45

Tissue

Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Nervous System 5 | 18,561
Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444

Target Family

Non-IDG 5 | 11,971

Grant Application

5R01DK058148-02 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Pro-neuropeptide Y NPY Tbio Non-IDG -3.81741 7285.3 401
Agouti-related protein AGRP Tbio Non-IDG -2.63067 471.4 168
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
Pro-thyrotropin-releasing hormone TRH Tbio Non-IDG -3.25958 1859.6 98
Leptin LEP Tbio Non-IDG -4.13745 15277.2 796